Lawrence G. Hamel
2011
In 2011, Lawrence G. Hamel earned a total compensation of $487.5K as Chief Development Officer at AcelRx Pharmaceuticals, a 22% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $70,892 |
|---|---|
| Option Awards | $75,330 |
| Salary | $283,000 |
| Stock Awards | $58,302 |
| Total | $487,524 |
Hamel received $283K in salary, accounting for 58% of the total pay in 2011.
Hamel also received $70.9K in non-equity incentive plan, $75.3K in option awards and $58.3K in stock awards.
Rankings
In 2011, Lawrence G. Hamel's compensation ranked 8,126th out of 10,747 executives tracked by ExecPay. In other words, Hamel earned more than 24.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,126 out of 10,747 | 24th |
Division Manufacturing | 2,988 out of 3,960 | 25th |
Major group Chemicals And Allied Products | 743 out of 1,038 | 28th |
Industry group Drugs | 533 out of 786 | 32nd |
Industry Pharmaceutical Preparations | 411 out of 571 | 28th |
Source: SEC filing on August 6, 2013.
Hamel's colleagues
We found four more compensation records of executives who worked with Lawrence G. Hamel at AcelRx Pharmaceuticals in 2011.